Paul Spearman

7.7k citations

140 papers · 5.8k indexed · 1 hit paper · h-index 44

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment

Papers in

Virology 87
- HIV Research and Treatment 85
Infectious Diseases 52
- HIV/AIDS drug development and treatment 25

Co-authors: Lee Ratner Lingmei Ding Vasundhara Varthakavi J. Hammonds Aaron Derdowski Barbara J. Stoll Andrés Camacho-González Jaang-Jiun Wang
Journals: Journal of Virology (24 papers)Virology (10 papers)Vaccine (9 papers)PLoS ONE (7 papers)The Journal of Infectious Diseases (6 papers)
Partner nations: United States Taiwan Czechia

In The Last Decade

Paul Spearman

139 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

Neonatal Infectious Diseases 2013 · 325 citations

Peers

Countries citing papers authored by Paul Spearman

Since Specialization

Citations

This map shows the geographic impact of Paul Spearman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Spearman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Spearman more than expected).

Fields of papers citing papers by Paul Spearman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Spearman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Spearman. The network helps show where Paul Spearman may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Spearman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Spearman Line = papers co-authored together Paul Spearman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenges and solutions for instituting an efficient maintenance program for laboratory equipment in Central Asian, and developing world, countries BMC Public Health ·Suzanne Ekeroth, George P. Schmid, David Hoos, Марк Ристић, Phyllis Della‐Latta, Paul Spearman, Artur Ramos, Bereket Alemayehu, Mathias Herweg, Hernandez-Tamayo Cassidy, Sylvie Gaire	2019	2
2	Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1 PLoS Pathogens ·J. Hammonds, Neal Beeman, Lingmei Ding, Hu Jiafang, Ashwanth C. Francis, Jaang-Jiun Wang, Gregory B. Melikyan, Paul Spearman	2017	72
3	EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression PLoS Pathogens ·Michael G. Currier, Sujin Lee, Christopher C. Stobart, Anne L. Hotard, Rémi Villenave, Jia Meng, Carla D. Pretto, Michael D. Shields, Minh-Thuy Nguyen, Paula Molina Terrón, Anitha Madasamy Srinivasan Babu, J. Hammonds, Stefanie A. Krumm, Paul Spearman, Richard K. Plemper, Kaori Sakamoto, R. Stokes Peebles, Ultan F. Power, Martin L. Moore	2016	61
4	A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques Nature Communications ·Sujin Lee, Minh-Thuy Nguyen, Michael G. Currier, Joe B. Jenkins, Elizabeth Strobert, Adriana E. Kajon, Ranjna Madan-Lala, Yury A. Bochkov, James E. Gern, Krishnendu Roy, Xiaoyan Lu, Dean D. Erdman, Paul Spearman, Martin L. Moore	2016	45
5	Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations Molecular Immunology ·Mark D. Hicar, Xuemin Chen, Spyros A. Kalams, Hakimuddin T. Sojar, Gary Landucci, Donald N. Forthal, Paul Spearman, James E. Crowe	2015	10
6	Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults Vaccine ·David I. Bernstein, Lisa A. Jackson, Shital M. Patel, Hana M. El Sahly, Paul Spearman, Nadine Rouphael, Thomas L. Rudge, Heather Hill, Johannes B. Goll	2014	9
7	The Intracellular Virus-Containing Compartments in Primary Human Macrophages Are Largely Inaccessible to Antibodies and Small Molecules PLoS ONE ·Hin Chu, Watcharee Rungapiromnan, Mingli Qi, Xu Yunjun, Xiaoyun Wen, Xuemin Chen, Lingmei Ding, Paul Spearman	2012	41
8	Tetherin/BST-2 Is Essential for the Formation of the Intracellular Virus-Containing Compartment in HIV-Infected Macrophages Cell Host & Microbe ·Hin Chu, Jaang-Jiun Wang, Mingli Qi, Jeong-Joong Yoon, Xuemin Chen, Xiaoyun Wen, J. Hammonds, Lingmei Ding, Paul Spearman	2012	68
9	Filamin A Protein Interacts with Human Immunodeficiency Virus Type 1 Gag Protein and Contributes to Productive Particle Assembly Journal of Biological Chemistry ·伊骞鹏, Ling Liu, Elvin Woodruff, Harry E. Taylor, J. Shawn Goodwin, Richard T. D’Aquila, Paul Spearman, James E. K. Hildreth, Xinhong Dong	2011	39
10	Emerging studies of human HIV-specific antibody repertoires Vaccine ·Mark D. Hicar, Spyros A. Kalams, Paul Spearman, James E. Crowe	2010	7
11	Pseudovirion Particles Bearing Native HIV Envelope Trimers Facilitate a Novel Method for Generating Human Neutralizing Monoclonal Antibodies Against HIV JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mark D. Hicar, Xuemin Chen, Bryan Briney, J. Hammonds, Jaang-Jiun Wang, Spyros A. Kalams, Paul Spearman, James E. Crowe	2010	23
12	Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C Virology ·Tao Wang, Wenyan Zhang, Chunjuan Tian, Bindong Liu, Yunkai Yu, Lingmei Ding, Paul Spearman, Xiao-Fang Yu	2008	39
13	Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers Vaccine ·Paul A. Goepfert, Georgia D. Tomaras, Helen Horton, David C. Montefiori, Guido Ferrari, Musyarapah Musyarapah, Gérald Voss, Marguerite Koutsoukos, Louise Pedneault, Pierre Vandepapelière, M. Juliana McElrath, Paul Spearman, Jonathan D. Fuchs, Beryl A. Koblin, William A. Blattner, Sharon E. Frey, Lindsey R. Baden, Clayton Harro, Thomas G. Evans	2006	71
14	Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV‐1 Genes or the Gene for Rabies Virus G Protein The Journal of Infectious Diseases ·Peter F. Wright, Jiří Městecký, M. Juliana McElrath, Michael C. Keefer, Geoffrey J. Gorse, Paul A. Goepfert, Zina Moldoveanu, David H. Schwartz, Paul Spearman, Raphaëlle El Habib, Michele Spring, Yuwei Zhu, Carol Smith, Jorge Flores, Kent J. Weinhold	2004	45
15	Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production Proceedings of the National Academy of Sciences ·Vasundhara Varthakavi, Rita M. Smith, Stephan Bour, Klaus Strebel, Paul Spearman	2003	135
16	Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core Virology ·J. Hammonds, Xuemin Chen, Lingmei Ding, Timothy Fouts, Alva Kaponen, Jan zur Megede, Susan W. Barnett, Paul Spearman	2003	37
17	Expression of Vaccinia E3L and K3L Genes by a Novel Recombinant Canarypox HIV Vaccine Vector Enhances HIV-1 Pseudovirion Production and Inhibits Apoptosis in Human Cells Virology ·Glodić Duško, Keith Limbach, James Tartaglia, J. Hammonds, Xuemin Chen, Paul Spearman	2001	19
18	QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans Vaccine ·Thomas G. Evans, M. Juliana McElrath, Thomas J. Matthews, David C. Montefiori, Kent J. Weinhold, Mark Wolff, Michael C. Keefer, Esper G. Kallás, Lawrence Corey, Geoffrey J. Gorse, Robert B. Belshe, Barney S. Graham, Paul Spearman, David H. Schwartz, Mark J. Mulligan, Paul A. Goepfert, Patricia Fast, Avelino Hiroshi Fujimoto, Michael F. Powell, Don Francis	2001	106
19	ACUTE ASEPTIC MENINGITIS SECONDARY TO INTRAVENOUS IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME The Pediatric Infectious Disease Journal ·Thomas G. Boyce, Paul Spearman	1998	10
20	HIV-2 Viral Protein X Association with the Gag p27 Capsid Protein Virology ·Robert M. Horton, Paul Spearman, Lee Ratner	1994	25

About Paul Spearman

Paul Spearman is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Structural Biology, having authored 140 papers that have together received 5.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (85 papers), HIV/AIDS drug development and treatment (25 papers), Immune Cell Function and Interaction (20 papers), Cytomegalovirus and herpesvirus research (14 papers), Respiratory viral infections research (12 papers), Mosquito-borne diseases and control (12 papers), Herpesvirus Infections and Treatments (11 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Virology (3.1k citations), Infectious Diseases (1.9k citations), Immunology (1.7k citations), Structural Biology (89 citations) and Epidemiology (2.0k citations). Paul Spearman has collaborated with scholars based in United States, Taiwan and Czechia. Frequent co-authors include Lee Ratner, Lingmei Ding, Vasundhara Varthakavi, J. Hammonds, Aaron Derdowski, Barbara J. Stoll, Andrés Camacho-González, Jaang-Jiun Wang, Yuan Lu and Rita M. Smith. Their work appears in journals such as Journal of Virology, Virology, Vaccine, PLoS ONE and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact